Jump Financial’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
Other funds holding JANX
Jump Financial's JANX Position: Q3 2026 in Review
Jump Financial reduced its Janux Therapeutics (JANX) stake by 4.7% in Q3 2026, selling an estimated $287K and leaving 344,611 shares worth $5.95M. The position accounts for 0.04% of the portfolio, ranked #542.
Jump Financial first reported a position in JANX in Q2 2023 and has held it in 10 quarters since. 204 funds tracked by Wall St. Rank hold JANX as of Q3 2026.
- Jump Financial held 344,611 shares of Janux Therapeutics worth $5.95M as of Q3 2026.
- Jump Financial sold 17,054 Janux Therapeutics shares in Q3 2026, an estimated $287K.
- Janux Therapeutics made up 0.04% of Jump Financial's portfolio in Q3 2026, its #542 holding.
- Jump Financial first reported a position in Janux Therapeutics in Q2 2023 and has held it in 10 quarters since.
- 204 funds tracked by Wall St. Rank held Janux Therapeutics as of Q3 2026.
Based on Jump Financial's 13F filing for Q3 2026, filed 13 Nov 2026.